Lexaria Bioscience Corp (LEXX)

[TonyX]

Japanese deal not that great

"In order to retain ongoing exclusivity, the negotiated minimum quarterly payments ("Payments") to Lexaria begin September 1, 2022 and, during the first five years of the Agreement, amount to US$4,527,500"

this is less than $1mm per year and it's only if the company want to retain exclusivity. Given Lexaria has no other potential deals on the horizon, they don't need to maintain exclusivity. So, in short, even if they make these payments, it doens't mean much for the company, and they aren't that likely to anyway.